Clinical Trial Update: Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 safety and efficacy trial evaluating electrotransfer of the AMEP plasmid for advanced or metastatic melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• AMEP plasmid (AMEP)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Melanoma | Phase 1 | Status: TERMINATED